/images/headbanner/44-GlobalRegulatoryAffairsCMCFiling.jpg
Global Regulatory Affairs CMC Filing
Head Banner

WuXi STA's dedicated Global Regulatory Affairs CMC Team offers CMC documentation support for IND, CTA, MAA, and NDA applications in western countries and China. Our highly experienced team works with your NCE programs to prepare Module 2 and Module 3 of your regulatory dossier through forward-looking gap analyses and meticulous preparation of source documents. Our dedicated team can add tremendous value to your development program and speed time to market. 

/images/services/template1/36-img-1.jpg
#EFEFEF
HQArticle_Head
#EFEFEF
  • CMC dossier preparation and technical review(IND/CTA/NDA for USA, Europe and China)
  • Consultation to evaluate strategy, planning and feasibility by staying abreast with key CMC activities, suggestion of any regulatory contribution
  • Gap analysis to evaluate documentation needs for filing readiness
  • Ensure that quality of source documents are ready for regulatory submission 
  • Support to fill any gaps through renowned WuXi STA CMC platform and WuXi AppTec R&D platform
  • Translation of written English documents to Chinese or vice versa (e.a.,CMC dossier,technical documents) to different filing purpose
HQListGroup
Why trust WuXi STA?
#EFEFEF
  • A team of highly skilled CMC professional, with average of ~10 years of pharmaceutical industry experience
  • In-depth regulatory CMC knowledge, with defined processes of thorough technical and quality control review in-house prior to client review
  • Multi-lingual ability to help respond to regulatory agency questions
  • Program and project managers to seamlessly coordinate across entire WuXi AppTec platform
HQListGroup
中文
EN
  • Home 首页
  • {{menu.Name}} {{menu.Name}}
      • {{twoMenu.Name}} {{twoMenu.Name}}
        • {{threeMenu.Name}} {{threeMenu.Name}}
          • {{fourMenu.Name}}
    • {{twoMenu.Name}}
  • Home 首页
  • EN 中文

{{item.headBannerTitle}}

  • Services & Solutions Overview
  • API Process Development & Manufacturing
  • Formulation Development & Manufacturing
  • WuXi TIDES (Oligonucleotide and Peptide CRDMO Services)
  • Analytical Development & Quality Control
  • Global Regulatory Affairs CMC Filing
  • About Us
  • Services and Solutions
  • News
  • Resources
  • Careers
  • Contact us

{{item.title}}

{{item.contentTitle}}

{{item.contentTitle}}

Click to learn more

{{item.title}}

{{item.title}}

{{secondGrids.title}}

{{item.table.title}}

  • {{grid.text}}

{{item.table.title}}

  • {{grid.text}}

{{item.title}}

{{item.content}}

  • {{art.subTitle}}

{{item.title}}

{{item.leftContent.title}}

{{item.rightContent.title}}

{{fa.title}}

{{fa.subTitle}}

{{fa.title}}

{{fa.subTitle}}

{{item.title}}

{{item.content}}

{{fa.title}}

{{item.title}}

{{item.title}}

{{art.articleTitle}}

{{art.articleContent}}

{{item.title}}

{{item.contentTitle}}

{{item.contentTitle}}

Click to learn more

  • About Us
  • News
  • Resource
  • Careers
  • Contact Us

Services & Solutions

  • API Process Development & Manufacturing
  • Drug Product Development & Manufacturing
  • WuXi TIDES (Oligonucleotide and Peptide CRDMO Services)
  • Analytical Development & Quality Control
  • Global Regulatory Affairs CMC Support
  • 关于我们
  • 新闻和活动
  • 资源中心
  • 职业发展
  • 联系我们

服务和解决方案

  • 原料药工艺研发与生产
  • 制剂工艺研发与生产
  • WuXi TIDES (寡核苷酸及多肽CRDMO服务)
  • 分析开发与质量控制
  • 全球申报事务药学支持

领英

药明康德

Copyright © 2020 STA Pharmaceutical Co. Ltd. Privacy Policy 隐私策略 Terms of Use 使用条款 沪公网安备 31011502018943号